The Effect of Continuous Intravenous Infusion of Lidocaine on PPCs and Prognosis in Emergency Surgical Patients With IAI

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-100
SponsorShanghai Zhongshan Hospital

About this trial

The main purpose of this study is to evaluate the impact of continuous 24-hour intravenous infusion of lidocaine on the incidence of PPCs in patients undergoing emergency laparotomy for intra-abdominal infection (IAI).The secondary objectives of this study are to assess the impact of continuous 24-hour intravenous lidocaine infusion on the proportion of patients requiring mechanical ventilation, protection of important organ function during the perioperative period, length of hospital stay, and outcomes within 30 days postoperatively.

Eligibility criteria

Qualifiers

Age >18 years, any gender.

Patients suspected of digestive tract perforation or obstruction based on physical examination, confirmed by imaging, requiring emergency surgical treatment.

The anesthesia method is general anesthesia

I or the patient's family have carefully read and signed the informed consent form

Disqualifiers

Have a history of local anesthesia drug allergy

Pregnant patients

Patients receiving renal replacement therapy

Patients with arrhythmias or heart failure (second or third-degree atrioventricular block or left ventricular ejection fraction(LVEF)

Trial design

Treatments tested in this trial

  • Lidocaine
  • Placebo

Treatment groups

428 Participants
are divided into 2 treatment groups

Sponsors and collaborators

Shanghai Zhongshan Hospital

Lead sponsor

The Affiliated Hospital of Xuzhou Medical University

Collaborator

West China Hospital

Collaborator